Literature DB >> 26608207

Diagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva.

Ivan Igaz1, Peter Igaz2.   

Abstract

Beside blood-borne circulating miRNAs, miRNAs have been identified in other body fluid and excrements including stool, bile, saliva, and urine. Given the direct link of these body fluids to certain organs, their analysis for potential diagnostic miRNA markers is plausible. Several independent findings underline the potential utility of stool-derived miRNAs in the diagnosis of colorectal and pancreatic cancer. Given the difficulties in the diagnosis of cholangiocellular cancer, biliary miRNAs might be envisaged as useful markers. Several miRNAs have been identified in the saliva that could be associated with diseases, including tumors of the oral cavity. The urinary pool of miRNAs could be exploited for the diagnosis of urinary tract diseases and some appear to enable early diagnosis. In this chapter, we present findings supporting the potential diagnostic utility of fecal, biliary, salivary, and urinary miRNAs focusing mostly on tumors.

Entities:  

Keywords:  Bile; Biomarker; Feces; Saliva; Urine; microRNA

Year:  2015        PMID: 26608207     DOI: 10.1007/978-3-0348-0955-9_11

Source DB:  PubMed          Journal:  Exp Suppl        ISSN: 1664-431X


  11 in total

Review 1.  Translating microRNAs into biomarkers: What is new for pediatric cancer?

Authors:  Ivna Néria Silva Ribamar de Carvalho; Renata Mendes de Freitas; Fernando Regla Vargas
Journal:  Med Oncol       Date:  2016-04-16       Impact factor: 3.064

2.  miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions.

Authors:  Eun-Ah Ye; Jena J Steinle
Journal:  Vision Res       Date:  2017-04-26       Impact factor: 1.886

Review 3.  Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2016-06-02

4.  The Potential Use of Salivary miRNAs as Promising Biomarkers for Detection of Cancer: A Meta-Analysis.

Authors:  Yuanjie Ding; Qing Ma; Fen Liu; Lei Zhao; Wenqiang Wei
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

5.  Redox regulation of microRNAs in endometriosis-associated pain.

Authors:  Kristeena Ray Wright; Brenda Mitchell; Nalini Santanam
Journal:  Redox Biol       Date:  2017-05-04       Impact factor: 11.799

Review 6.  The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.

Authors:  Nina Nayara Ferreira Martins; Kelly Cristina da Silva Oliveira; Amanda Braga Bona; Marília de Arruda Cardoso Smith; Geraldo Ishak; Paulo Pimentel Assumpção; Rommel Rodríguez Burbano; Danielle Queiroz Calcagno
Journal:  Gastroenterol Res Pract       Date:  2016-12-27       Impact factor: 2.260

7.  Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.

Authors:  Chiara Romani; Elisa Salviato; Alberto Paderno; Laura Zanotti; Antonella Ravaggi; Alberto Deganello; Giulia Berretti; Tommaso Gualtieri; Sergio Marchini; Maurizio D'Incalci; Davide Mattavelli; Cesare Piazza; Paolo Bossi; Chiara Romualdi; Piero Nicolai; Eliana Bignotti
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

8.  Saliva RNA Biomarkers of Gastrointestinal Dysfunction in Children With Autism and Neurodevelopmental Disorders: Potential Implications for Precision Medicine.

Authors:  David Q Beversdorf; Kristin Sohl; David Levitskiy; Priscilla Tennant; Robin P Goin-Kochel; Rebecca C Shaffer; Alexandra Confair; Frank A Middleton; Steven D Hicks
Journal:  Front Psychiatry       Date:  2022-01-20       Impact factor: 4.157

9.  Aberrant Non-Coding RNA Expressed in Gastric Cancer and Its Diagnostic Value.

Authors:  Zhilong Yu; ZeYin Rong; Jinxin Sheng; Zai Luo; Jianming Zhang; Tengfei Li; Zhonglin Zhu; Zhongmao Fu; Zhengjun Qiu; Chen Huang
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

10.  Serum microRNA profiling in patients with glioblastoma: a survival analysis.

Authors:  Hua Zhao; Jie Shen; Tiffany R Hodges; Renduo Song; Gregory N Fuller; Amy B Heimberger
Journal:  Mol Cancer       Date:  2017-03-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.